Seelos Therapeutics, Inc. - Common Stock (SEEL)

Seelos Therapeutics is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders and other neurodegenerative diseases

The company is engaged in advancing a diverse pipeline of product candidates that aim to address significant unmet medical needs, leveraging scientific research and clinical expertise to offer potential solutions for conditions such as depression, anxiety, and traumatic brain injury. Seelos is committed to harnessing the power of cutting-edge technologies to improve the lives of patients and provide new options for treatment.